Abstract:Objective: Using clotrimazole vaginal tablet as a positive control, to evaluate the results of clotrimazole vaginal expansion suppository in the treatment of mild and moderate vulvovaginal candidiasis in terms of efficacy, patient satisfaction, side effects, and recurrence rate. Methods: This study was jointly conducted by 5 hospitals from August 2017 to October 2018, patients with mild and moderate vulvovaginal candidiasis confirmed by fungal culture and symptoms scores were selected. They were randomized to experimental group and control group as 1∶1 ratio. In the experimental group (n=105), the subjects applied clotrimazole vaginal expansion suppository (150 mg) daily at night for 7 days. In the control group (n=106), the subjects used a single dose of clotrimazole vaginal tablet (500 mg). Follow-ups were performed at (8±3) and (30±5) days after the discontinuation of the drugs, respectively. The difference in clinical symptoms and signs scores was used to evaluate the improvement of clinical symptoms, and the patient's satisfaction and side effects were recorded. Results: At the first follow-up, the experimental group and control group were followed up by fungal culture on the cure rate [66.7% (70/105) versus 63.2% (67/106), P>0.05] and total effective rate [98.1% (103/105) versus 99.1% (105/106), P>0.05], the differences were not statistically significant. At the second follow-up, the recurrence rates of the experimental group and the control group were 5.7% (4/70) and 14.9% (10/67), respectively, with no significant difference (P>0.05). In the evaluation of patient satisfaction, the leakage of the drug in the experimental group was significantly better than that in the control group (P<0.01). The side effects mainly included vaginal stimulation, itching and burning sensation, and there was no statistical difference between the two groups (χ2=1.070, P=0.586). Conclusions: In the treatment of mild and moderate vulvovaginal candidiasis, clotrimazole vaginal expansion suppository is no less effective than clotrimazole vaginal tablet, and there is no significant difference in the recurrence rate between the two. In terms of patient satisfaction, clotrimazole vaginal expansion suppository is superior to clotrimazole vaginal tablet.

Analysis on the change of lactobacillus before and after treatment of SVVC patients with Canesten vaginal tablets and Micronazole vaginal soft capsules

Clinical Study on Vulvovaginal Candidiasis by the Treatment Using Lactobacillus

A Study with Three Regimen for Severe Vulvovaginal Candidiasis

Comparison of Effects of Miconazolenitrate Suppository on Recurrent Vulvovaginal Candidiasis

Study on the effect of combined and sequential therapy of Lactobacillus agents and antifungal drugs in the treatment of severe vaginal candidiasis

Correlation of In Vitro Miconazole Nitrate Sesceptibilty with Clinical Outcome for Complicated Vulvovaginal Candidiasis

A Three Day Study with Miconazole Ovula 400mg and Cream in Vulvovaginal Candidiasis

Analysis of the Vaginal Microecology in Patients with Severe Vulvovaginal Candidiasis

The microecological evaluation of vaginal microflora in the women of serious vulvovaginal candidiasis.

The Restoration of the Vaginal Microbiota after Treatment for Bacterial Vaginosis with Metronidazole or Probiotics

The drug susceptibility in vitro of normal vaginal Lactobacillus to six different antifungal drugs

Miconazole Nitrate Vaginal Suppository 1,200 Mg Versus Oral Fluconazole 150 Mg in Treating Severe Vulvovaginal Candidiasis

The Efficacy and Safety of Clotrimazole Vaginal Tablet Vs. Oral Fluconazole in Treating Severe Vulvovaginal Candidiasis.

Efficacy of Limosilactobacillus fermentum in the management of vulvovaginal candidiasis: comparative analysis with topical miconazole in a single-blind randomized clinical trial

Investigate the Pathogen Flora and the Treatment of Recurrent Vulvovaginal Candidiasis

[A Multicenter, Randomized, Open and Positive Parallel Controlled Clinical Study of Clotrimazole Vaginal Expansion Suppository and Vaginal Tablet in the Treatment of Mild and Moderate Vulvovaginal Candidiasis].

Correlation Analysis of Vaginal Microbiome Changes and Bacterial Vaginosis Plus Vulvovaginal Candidiasis Mixed Vaginitis Prognosis

Effectiveness of combined use of sodium bicarbonate sitz bath prescription and vaginal nystatin suppository in the treatment of patients with fungal vaginitis

An Epidemic Investigation on Vulvovaginal Candidiasis (VVC) and Recurrence Vulvovaginal Candidiasis (RVVC) Patients

Species Distribution and in Vitro Antifungal Susceptibility of Vulvovaginal Candida Isolates in China.

A Randomized Clinical Trial of the Efficacy and Safety of Terconazole Vaginal Suppository Versus Oral Fluconazole for Treating Severe Vulvovaginal Candidiasis.